Breaking News Instant updates and real-time market news.

DPS

Dr Pepper Snapple

$87.48

2.23 (2.62%)

, PEP

PepsiCo

$102.89

0.63 (0.62%)

16:16
11/22/16
11/22
16:16
11/22/16
16:16

On The Fly: Top stock stories for Tuesday

Stocks began the day in positive territory and established new all-time highs for the Dow, S&P and Nasdaq in the process. After moving past some milestone levels, including Dow 19,000 and S&P 2,200, the averages weakened and ultimately crossed into negative territory. The losses were modest until another wave of buying came in and moved the averages back above their previous highs. ECONOMIC NEWS: In the U.S., existing home sales climbed 2.0% to a 5.6M rate in October, the strongest since early 2007. The Richmond Fed's manufacturing index rose to 4 in November, an 8 point increase. COMPANY NEWS: Dr Pepper Snapple (DPS) announced that it has reached an agreement to acquire Bai Brands and its complete portfolio of premium antioxidant infused beverages. The cash purchase price of $1.7B includes a tax benefit of approximately $400M on a net present value basis and will be financed through new unsecured notes and short term commercial debt. Following the announcement, shares of Dr Pepper Snapple rose 2.6%. In other beverage industry M&A news, PepsiCo (PEP) announced that it has entered into a definitive agreement to acquire KeVita, a North American creator of fermented probiotic and kombucha beverages. Upon closing, KeVita will continue to operate independently with its production and bottling facilities located in Oxnard, California... Shares of Medtronic (MDT) dropped 8.7% after the medical device maker reported weaker than expected quarterly revenue driven by slower growth in its diabetes and heart product units. Additionally, the company cut its adjusted earnings forecast for 2017. MAJOR MOVERS: Among the notable gainers was Burlington Stores (BURL), which advanced 16% after the company announced better than expected third quarter results. Additionally, Dollar Tree (DLTR) rose over 8% after the discount store chain reported stronger than expected quarterly earnings and lifted its guidance. Among the noteworthy losers was Palo Alto Networks (PANW), which fell 13.2% after the company reported first quarter results. While revenue increased in the latest quarter, the growth was Palo Alto Networks' slowest pace as a public company and the deceleration is expected to continue. Also lower was Patterson Companies (PDCO), which dropped nearly 17% after the company reported worse than expected quarterly results, lowered its guidance for 2017 and announced it has elected not to extend its exclusivity selling agreement with Dentsply Sirona (XRAY) beyond September 2017. Additionally, FireEye (FEYE) slid about 5.5% after Goldman Sachs downgraded the stock to Sell, saying that the Internet security company's transitions present underappreciated risks. INDEXES: The Dow rose 67.18, or 0.35%, to 19,023.87, the Nasdaq gained 17.49, or 0.33%, to 5,386.35, and the S&P 500 advanced 4.76, or 0.22%, to 2,202.94.

DPS

Dr Pepper Snapple

$87.48

2.23 (2.62%)

PEP

PepsiCo

$102.89

0.63 (0.62%)

MDT

Medtronic

$73.57

-7.01 (-8.70%)

BURL

Burlington Stores

$85.97

11.79 (15.89%)

DLTR

Dollar Tree

$88.68

6.69 (8.16%)

PANW

Palo Alto Networks

$139.73

-21.33 (-13.24%)

PDCO

Patterson Companies

$39.56

-7.95 (-16.73%)

XRAY

Dentsply Sirona

$59.85

-0.03 (-0.05%)

FEYE

FireEye

$13.11

-0.76 (-5.48%)

  • 22

    Nov

  • 22

    Nov

  • 22

    Nov

  • 22

    Nov

  • 22

    Nov

  • 29

    Nov

  • 05

    Dec

  • 07

    Dec

  • 08

    Dec

  • 08

    Dec

  • 09

    Dec

DPS Dr Pepper Snapple
$87.48

2.23 (2.62%)

10/04/16
10/04/16
DOWNGRADE

Hold
Dr Pepper Snapple downgraded on Bai Brands potential sale at Evercore ISI
As previously reported, Evercore ISI downgraded Dr Pepper Snapple to Hold form Buy. Analyst Robert Ottenstein said reports that Bai Brands is looking for a new owner are credible and could change investor's psychology on the stock and its Allied Brands business. The analyst believes Bai Brands will get sold and result in loss of distribution, negatively impacting earnings by 20c-25c. Further, Ottenstein said consumers are increasingly concerned about sugar and it is on the radar screen of local governments as a revenue source.
10/04/16
EVER
10/04/16
DOWNGRADE
EVER
Hold
Dr Pepper Snapple downgraded to Hold from Buy at Evercore ISI
11/22/16
GSCO
11/22/16
NO CHANGE
GSCO
Sell
Goldman says Dr Pepper deal should boost growth, but dilutive in near-term
Goldman Sachs analyst Judy Hong said Dr Pepper's announcement of a deal for Bai Brands, one of the company's best performing Allied Brands, is not unexpected and should boost Dr Pepper's growth profile. However, the acquisition is expected to be dilutive near-term and increases Dr Pepper's leverage, noted the analyst, who keeps a Sell rating on the stock.
10/04/16
10/04/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Underperform from Market Perform at Raymond James with analyst David Long saying the fallout from the unauthorized account openings will result in continued under performance. The analyst said several additional investigations, lawsuits, and fines have been announced, resulting in a still cloudy outlook. 2. Kinder Morgan (KMI) downgraded to Hold from Buy at Stifel analyst Selman Akyol citing valuation. 3. GrubHub (GRUB) downgraded to Hold from Buy at Stifel with analyst John Egbert citing valuation. 4. Dr Pepper Snapple (DPS) downgraded to Hold from Buy at Evercore ISI with analyst Robert Ottenstein saying reports that Bai Brands is looking for a new owner are credible and could change investor's psychology on the stock and its Allied Brands business. 5. Dollar Tree (DLTR) downgraded to Neutral from Buy at Cleveland Research with the firm saying sales trends appear to have slowed further at Family Dollar as the company struggles with increased price competition, difficult comps, and strategy headwinds. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
PEP PepsiCo
$102.89

0.63 (0.62%)

09/15/16
FBCO
09/15/16
INITIATION
FBCO
Outperform
PepsiCo initiated with an Outperform at Credit Suisse
09/15/16
FBCO
09/15/16
INITIATION
Target $121
FBCO
Outperform
PepsiCo initiated with an Outperform at Credit Suisse
Credit Suisse analyst Laurent Grandet initiated coverage on PepsiCo with an Outperform and a $121 price target. Grandet does not believe the market is giving PepsiCo enough credit for Frito-Lay's marketing and financial strength and the rebalancing of the US beverages portfolio towards faster growing noncarbonated beverages.
09/16/16
09/16/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. GoPro (GPRO) initiated with a Buy at BofA/Merrill. 2. JetBlue (JBLU) initiated with an Outperform at Imperial Capital. 3. PepsiCo (PEP), Dr Pepper Snapple (DPS), and Monster Beverage (MNST) were initiated with an Outperform at Credit Suisse, while the firm initiated Boston Beer (SAM) with an Underperform. Credit Suisse also initiated Coca-Cola (KO) and Constellation Brands (STZ) with a Neutral. 4. lululemon (LULU) initiated with a Positive at Susquehanna. 5. Target (TGT) coverage assumed with a Neutral at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/29/16
STFL
09/29/16
DOWNGRADE
STFL
Hold
Coca-Cola downgraded following Pepsi results at Stifel
As noted earlier, Stifel analyst Mark Swartzberg downgraded Coca-Cola (KO) to Hold from Buy. The analyst downgraded the stock after Pepsi (PEP) reported better than expected Q3 results. The analyst says that Coca-Cola's and Pepsi's organic EPS growth appears to be similar, but he believes that Pepsi is less vulnerable to foreign exchange fluctuations. Additionally, he believes that Coca Cola European Bottlers (CCE) is a better investment than Coca-Cola because of the large amount of revenue synergies which that Coca Cola European Bottlers has identified.
MDT Medtronic
$73.57

-7.01 (-8.70%)

11/14/16
EVER
11/14/16
NO CHANGE
EVER
Medtronic, Edwards Lifesciences defended at Evercore ISI
11/15/16
LEER
11/15/16
NO CHANGE
LEER
Edwards Lifesciences, Medtronic selloff overdone, says Leerink
Leerink analyst Danielle Antalffy notes that both Edwards Lifesciences (EW) and Medtronic (MDT) traded down in reaction to a presentation of the German Aortic Valve Registry data in intermediate risk patients. However, she believes the selloff is overdone, with no change to her estimated total addressable transcatheter aortic valve replacement, or TAVR, market opportunity as there are key baseline characteristic differences between both the surgical valve and TAVR groups that skews the data, and randomized controlled clinical trial data trumps registry data.
11/02/16
BMOC
11/02/16
NO CHANGE
BMOC
Dexcom still has positive catalysts, says BMO Capital
After Dexcom reported higher than expected Q3 revenue but said it does not expect its 2016 revenue to come in above its previous guidance range, BMO Capital analyst Joanne Wuensch says that the company's Q4 and 2017 results will probably be negatively impacted by Medtronic's (MDT) upcoming MiniMed 670G product. Nonetheless, the analyst says that the pending non-adjunctive label for Dexcom's CGM "can make waves," while it has "ample" room for growth in its "vastly underserved" market, as its "technology is nowhere near its full potential." The analyst cut her price target on the shares to $90 from $112 but keeps an Outperform rating on the stock.
11/14/16
PIPR
11/14/16
NO CHANGE
PIPR
Overweight
Piper would buy TAVR names on 'GARY' registry weakness
Piper Jaffray analyst Brooks West attributes today's weakness in transcatheter aortic valve replacement makers Medtronic (MDT), Edwards Lifesciences (EW) and Boston Scientific (BSX) to a presentation at the AHA meeting of data from the German Aortic Valve Registry, or "GARY," comparing one year outcomes for patients at intermediate surgical risk who underwent isolated interventional versus conventional surgical aortic valve replacement for severe symptomatic aortic valve stenosis. The data showed a surprisingly negative result, but prior debates around the "GARY" led to no impact on TAVR volumes and West is "skeptical of the results," he tells investors. The firm has Overweight ratings on all three stocks mentioned above.
BURL Burlington Stores
$85.97

11.79 (15.89%)

11/09/16
COWN
11/09/16
NO CHANGE
Target $90
COWN
Outperform
Burlington Stores short report has several unfair characterizations, says Cowen
Cowen analyst John Kiernan noted Burlington faced several negative headlines on third party credit card data, poor weather trends, and retail traffic. He also said a recent "short report" regarding Burlington had several unfair characterizations. Kiernan maintained his Outperform rating and $90 price target on Burlington Store shares.
09/30/16
GUGG
09/30/16
INITIATION
GUGG
Neutral
Burlington Stores initiated with a Neutral at Guggenheim
09/26/16
BOFA
09/26/16
NO CHANGE
Target $95
BOFA
Buy
Burlington Stores price target raised to $95 from $90 at BofA/Merrill
BofA/Merrill analyst Lorraine Hutchinson believes Burlington will generate strong comps in 2H 2016 due to positive supply chain dislocations, the Hanjin bankruptcy causing competitor product delays, and store closings at Macy's. The analyst reiterates his Buy rating on Burlington and raised its price target to $95 from $90.
08/26/16
08/26/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Seaport Global upgraded PetroQuest (PQ) to Buy and raised its price target to $5 from $4, citing reduced near-term balance sheet concerns and a potential Cotton Valley joint-venture partner by year-end. 2. MKM Partners upgraded Burlington Stores (BURL) to Buy from Neutral and increased its price target to $94 from $73. The analyst said two quarters of comp beats demonstrate strong momentum and sees catalysts for continued comp growth, continued refinement of the offprice model, outsized growth in home and beauty, and gross margin expansion. 3. Credit Suisse upgraded Petrobras (PBR) to Neutral and raised its price target to $8.60 from $2. The analyst believes management can add value through cost and capex cuts, divestments, fuel pricing, and strategic changes. 4. HSBC upgraded Southern Copper (SCCO) to Buy and raised its price target to $31.50 from $27. The analyst believes copper prices have bottomed and expects better production growth, higher by-product commodity prices, increasing free cash flow, and an improving balance sheet. 5. Northcoast upgraded A. Schulman (SHLM) to Buy and established a $30 price target. The analyst said risk/reward is favorable and sees catalysts from the reintroduction of Joe Gingo as CEO and his business plan review. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
DLTR Dollar Tree
$88.68

6.69 (8.16%)

11/22/16
FBCO
11/22/16
NO CHANGE
Target $75
FBCO
Underperform
Dollar Tree 'not worth chasing' after better than feared Q3, says Credit Suisse
Credit Suisse analyst Edward Joseph Kelly Jr. noted that Dollar Tree's Q3 results were "better than feared," as improvement at the core brand offset Family Dollar brand softness, but he believes the stock appears to be overreacting. Family Dollar still has challenges and the turnaround the market is assuming will be hard, said Kelly, who keeps an Underperform rating on the stock but raised his price target to $75 from $69 on the Dollar Tree shares.
11/15/16
JRCO
11/15/16
UPGRADE
JRCO
Accumulate
Dollar Tree upgraded to Accumulate from Hold at Johnson Rice
11/14/16
UBSW
11/14/16
NO CHANGE
Target $90
UBSW
Buy
Dollar Tree valuation is quite favorable, says UBS
UBS analyst Michael Lasser said Dollar Tree's valuation remains favorable. Lasser said top-line trends for Q3 were probably subdued but with the shares trading at a discount and its PE trading at just a sight premium to the S&P, soft trends will be reflective of a tough environment rather than a change in productivity. The analyst said margins should continue to gain as synergies with is Family Dollar acquisition accelerate. Lasser reiterated his Buy rating and $90 price target on Dollar Tree shares.
11/15/16
11/15/16
UPGRADE

Accumulate
Dollar Tree upgraded to Accumulate on Family Dollar progress at Johnson Rice
As previously reported, Johnson Rice upgraded Dollar Tree to Accumulate from Hold. Analyst David Mann has increased confidence in the long-term transformation at Family Dollar, the strong management team, lower investor expectations, and more attractive valuation.
PANW Palo Alto Networks
$139.73

-21.33 (-13.24%)

11/22/16
MAXM
11/22/16
NO CHANGE
Target $185
MAXM
Buy
Palo Alto Networks technology still 'best-in-class,' says Maxim
Maxim analyst Nehal Chokshi blames Palo Alto Networks' Q1 revenue miss and softer Q2 guidance to an extension in its large deal sales cycle. However, despite seeing limited upside for the remainder of FY17, he continues to believe that Palo Alto has a best-in-class network security capability and keeps a Buy rating and $185 price target on the shares.
11/22/16
PIPR
11/22/16
NO CHANGE
Target $178
PIPR
Overweight
Palo Alto Networks still posting 31% revenue growth, says Piper Jaffray
Piper Jaffray analyst Andrew Nowinski points out that despite the "disappointing" Q1 results, Palo Alto Networks (PANW) is still generating 31% revenue growth, which is three-times above closest competitor Cisco (CSCO). He recommends investors hold the stock through the selling pressure. Nowinski lowered his price target for Palo Alto shares to $178 from $184 and keeps an Overweight rating on the name.
11/22/16
STFL
11/22/16
NO CHANGE
STFL
Buy
Palo Alto Networks long-term thesis remains intact, says Stifel
Stifel analyst Gur Talpaz said Palo Alto Networks missed Q1 due to revenue and billings estimates due to an elongated sales cycle that resulted in some larger deals slipping into Q2. The analyst sees a relatively healthy enterprise security spending environment but with additional deal scrutiny and higher levels of discounting among Palo Alto's primary competitors. However, Talpaz is encouraged by improving traction of the company's Traps and VM-Series solutions and views Q1 results as a hiccup and said his long-term Buy thesis is intact.
11/22/16
PACS
11/22/16
NO CHANGE
PACS
Palo Alto Networks long-term opportunity still positive, says Pacific Crest
After Palo Alto reported weaker than expected results, Pacific Crest analyst Rob Owens blames the miss on "extended deal cycles requiring additional approval." .However, the analyst continues to believe that its growth is "impressive," and he thinks that it still has one of the best longer term outlooks of any IT security company.He keeps a $190 price target and an Overweight rating on the shares.
PDCO Patterson Companies
$39.56

-7.95 (-16.73%)

10/05/16
UBSW
10/05/16
INITIATION
Target $48
UBSW
Neutral
Patterson Companies initiated with a Neutral at UBS
Target $48.
11/21/16
BARD
11/21/16
NO CHANGE
BARD
Outperform
Baird expects Amazon.com distribution announcement with Patterson
Following industry conversions, Baird analyst Jeff Johnson expects Patterson Companies (PDCO) to announce an Amazon.com (AMZN) distribution agreement tomorrow. What the analyst hadnt considered and is now hearing is that Amazon could fulfill orders placed through Patterson's order portal, lowering Patterson's fulfillment costs and given the company breathing room as it pursues DSO deals. Johnson rates Patterson a Neutral with a $48 price target.
11/01/16
NRCS
11/01/16
NO CHANGE
NRCS
Amazon.com should partner with Patterson Companies, says Northcoast
Northcoast said Amazon.com (AMZN) has a strong interest in entering the dental market and has spent time and resources attempting to build relationships with manufacturers and distributors to gain product procurement, which so far has been unsuccessful. The firm's analyst said Patterson (PDCO) is aggressively trying to reinvent how dental distribution will occur in the future and is building a new IT backbone, making huge investments in technical service. Northcoast said Patterson is on a path to disrupt the industry and could accelerate this effort with a partnership with Amazon. The firm continues to view Patterson as undervalued, with out without Amazon, and recommends investors build positions at this time.
11/22/16
PIPR
11/22/16
NO CHANGE
PIPR
Patterson cancellation a positive for Dentsply, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien believes Patterson Companies (PDCO) cancelling its exclusive selling agreement with legacy Sirona products beyond September 2017 as positive for Dentsply Sirona (XRAY). The move is unsurprising given the changing industry dynamics, O'Brien tells investors in a research note. He points out that the initial exclusive agreement was established in 1998. Assuming Henry Schein (HSIC) starts selling legacy Sirona equipment, the cancellation is a positive for Dentsply as this will ultimately allow the company to increase cross-selling opportunities with those customers, O'Brien argues. He's been calling for a cancellation of the exclusive selling agreement with Patterson saying Dentsply has been adamant about realizing sales synergies through increased cross-selling opportunities. The analyst reiterates an Overweight rating on Dentsply with a $70 price target. Patterson in pre-market trading is down 17% to $39.20 after reporting a decline in North American dental consumables sales of 2.5%. Dentsply shares are down 2% to $58.40.
XRAY Dentsply Sirona
$59.85

-0.03 (-0.05%)

09/22/16
09/22/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: Packaging Corp. (PKG) initiated with a Sell at Goldman. 2. Netlist (NLST) initiated with a Buy at B. Riley. 3. Weyerhaeuser (WY) initiated with a Conviction Buy at Goldman. 4. bluebird bio (BLUE) reinstated with a Buy at Roth Capital. 5. Dentsply Sirona (XRAY) initiated with a Neutral at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/01/16
11/01/16
UPGRADE
Target $69

Overweight
Dentsply Sirona upgraded on growth, valuation at Morgan Stanley
As previously reported, Morgan Stanley upgraded Denstply Sirona to Overweight from Equal Weight and raised its price target to $69 from $65. Analyst Steve Beuchaw said Densply's relative valuation weakness positions the company for better performance despite negative dental market sentiment. He expects Dentsply's organic growth to accelerate in 2017 driven by digital dentistry adoption, a focus on commercial headcount, easing digital equipment comps, and revenue synergies. Beauchaw expects the company's double digit free cash flow growth potential to improve investor sentiment.
11/01/16
MSCO
11/01/16
UPGRADE
MSCO
Overweight
Dentsply Sirona upgraded to Overweight from Equal Weight at Morgan Stanley
FEYE FireEye
$13.11

-0.76 (-5.48%)

11/22/16
GSCO
11/22/16
DOWNGRADE
Target $11
GSCO
Sell
FireEye downgraded to Sell from Neutral at Goldman
Goldman analyst Gabriela Borges downgraded FireEye to Sell and lowered its price target to $11 from $15. The analyst said the Street is underestimating medium near-term risk from several product and business model transitions. He expects margins to remain pressured in 2017 due to changes in customer buying patterns and believes FireEye's move into the mid-market will be difficult to execute.
11/04/16
OPCO
11/04/16
NO CHANGE
Target $28
OPCO
Outperform
FireEye price target lowered to $28 from $33 at Oppenheimer
Oppenheimer analyst Shaul Eyal lowered his price target for FireEye to $28 from $33 on valuation. Following the company's "solid" Q3 results, the analyst is encouraged by the ongoing operational improvement as well as overall demand and product trends. Further, Eyal says it appears that FireEye's management team "has turned a corner steering it in the right direction." The analyst reiterates an Outperform rating on the shares.
10/24/16
10/24/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AT&T (T)downgraded to Hold from Buy at Drexel Hamilton, and to Market Perform from Outperform at Cowen. 2. Time Warner (TWX) downgraded to Neutral from Outperform at Credit Suisse, to Neutral from Buy at MKM Partners, to Neutral from Conviction Buy at Goldman, to Neutral from Outperform at Macquarie, to Hold from Buy at Pivotal Research, to Neutral from Overweight at Atlantic Equities, to Neutral from Buy at MoffettNathanson, and to Sector Perform from Outperform at RBC Capital. 3. Everyday Health (EVDY) downgraded to Neutral from Outperform at Credit Suisse, to Hold from Buy at SunTrust, and to Market Perform from Outperform at Leerink. 4. Reynolds American (RAI) downgraded to Underperform from Outperform at CLSA with analyst Michael Lavery saying British American Tobacco's (BTI) $56.50 offer for Reynolds is a moving target and is now worth $55.50. 5. FireEye (FEYE) downgraded to Underweight from Equal-Weight at First Analysis with analyst Howard Smith saying the security spending environment favors other players in the space. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/21/16
FANA
10/21/16
DOWNGRADE
Target $11
FANA
Underweight
FireEye downgraded to Underweight from Equal-Weight at First Analysis
First Analysis analyst Howard Smith downgraded FireEye to Underweight saying the security spending environment favors other players in the space. The company's high cash burn will drive share underperformance, Smith tells investors in a research note. He cut his price target for the stock to $11 from $15. FireEye closed the trading day up 36c to $12.64.

TODAY'S FREE FLY STORIES

CG

Carlyle Group

$15.75

0.45 (2.94%)

, GS

Goldman Sachs

$240.40

-1.05 (-0.43%)

14:19
12/09/16
12/09
14:19
12/09/16
14:19
Periodicals
Carlyle-owned PPD looking into potential $5B sale, WSJ says »

Pharmaceutical Product…

CG

Carlyle Group

$15.75

0.45 (2.94%)

GS

Goldman Sachs

$240.40

-1.05 (-0.43%)

JPM

JPMorgan

$84.99

-0.13 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jan

  • 28

    Feb

  • 14

    Jul

  • 12

    Oct

BA

Boeing

$156.24

0.85 (0.55%)

, SFTBF

SoftBank

$68.84

3.052 (4.64%)

14:18
12/09/16
12/09
14:18
12/09/16
14:18
Hot Stocks
Trump + Stocks: The Week In Review »

Boeing and the…

BA

Boeing

$156.24

0.85 (0.55%)

SFTBF

SoftBank

$68.84

3.052 (4.64%)

S

Sprint

$8.52

-0.225 (-2.57%)

TMUS

T-Mobile

$58.55

0.16 (0.27%)

AZN

AstraZeneca

$27.12

0.8466 (3.22%)

BMY

Bristol-Myers

$56.95

1.7216 (3.12%)

LLY

Eli Lilly

$67.95

0.76 (1.13%)

GSK

GlaxoSmithKline

$37.82

0.4341 (1.16%)

JNJ

Johnson & Johnson

$112.02

1.03 (0.93%)

MRK

Merck

$61.24

1.115 (1.85%)

NVS

Novartis

$69.79

2.2 (3.25%)

PFE

Pfizer

$31.73

0.79 (2.55%)

RHHBY

Roche

$27.08

-0.36 (-1.31%)

SNY

Sanofi

$40.34

0.565 (1.42%)

HELE

Helen of Troy

$81.70

1.2 (1.49%)

PLAY

Dave & Buster's

$56.62

-0.38 (-0.67%)

KSU

Kansas City Southern

$85.97

-0.25 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

  • 15

    Dec

  • 15

    Dec

  • 04

    Jan

  • 09

    Jan

  • 09

    Jan

  • 16

    Feb

  • 08

    Mar

  • 29

    Mar

$NYE

NYSE Market Internals

14:16
12/09/16
12/09
14:16
12/09/16
14:16
Technical Analysis
NYSE market internals summary »

Breadth is mixed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

14:16
12/09/16
12/09
14:16
12/09/16
14:16
Technical Analysis
NASDAQ market internals summary »

Volume is heavy for this…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSTG

Pure Storage

$12.16

-0.17 (-1.38%)

14:12
12/09/16
12/09
14:12
12/09/16
14:12
Conference/Events
Pure Storage participates in a conference call with Stifel »

Stifel's Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 12

    Dec

  • 12

    Jan

  • 13

    Jan

  • 09

    Dec

IX

ORIX Corp

$82.04

0.99 (1.22%)

14:10
12/09/16
12/09
14:10
12/09/16
14:10
Upgrade
ORIX Corp rating change  »

ORIX Corp upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIG

Transocean

$15.43

0.585 (3.94%)

14:10
12/09/16
12/09
14:10
12/09/16
14:10
Options
Transocean short-term puts active as shares see strength »

Transocean short-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

NMR

Nomura

$6.70

0.22 (3.40%)

14:08
12/09/16
12/09
14:08
12/09/16
14:08
Upgrade
Nomura rating change  »

Nomura upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MET

MetLife

$57.13

-0.06 (-0.10%)

14:06
12/09/16
12/09
14:06
12/09/16
14:06
Downgrade
MetLife rating change  »

MetLife downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

14:05
12/09/16
12/09
14:05
12/09/16
14:05
General news
Treasury Action: next week's auctions could be difficult »

Treasury Action: next…

QQQ

NASDAQ 100 Index Tracking Stock

$118.57

0.21 (0.18%)

14:00
12/09/16
12/09
14:00
12/09/16
14:00
Options
Bullish yearend play in the PowerShares QQQ ETF »

Bullish yearend play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:50
12/09/16
12/09
13:50
12/09/16
13:50
General news
Action Economics Survey results: equities continue to charge ahead »

Action Economics Survey…

CFX

Colfax

$39.04

-0.245 (-0.62%)

13:49
12/09/16
12/09
13:49
12/09/16
13:49
Conference/Events
Colfax to hold a conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

13:45
12/09/16
12/09
13:45
12/09/16
13:45
General news
FX Action: USD-JPY »

FX Action: USD-JPY moved…

NRE

Northstar Realty Europe Corp.

$12.13

0.36 (3.06%)

, NSAM

NorthStar Asset Management

$15.09

0.09 (0.60%)

13:44
12/09/16
12/09
13:44
12/09/16
13:44
Hot Stocks
Bow Street confirms $13 per share offer for Northstar Realty Europe Corp. »

Bow Street, which holds a…

NRE

Northstar Realty Europe Corp.

$12.13

0.36 (3.06%)

NSAM

NorthStar Asset Management

$15.09

0.09 (0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

CALA

Calithera Biosciences

$3.20

-0.05 (-1.54%)

13:44
12/09/16
12/09
13:44
12/09/16
13:44
Conference/Events
Calithera Biosciences to hold a conference call »

Management discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

BAC

Bank of America

$23.03

0.075 (0.33%)

13:40
12/09/16
12/09
13:40
12/09/16
13:40
Options
Eight year highs and flat skew draw ratio call spreader in Bank of America »

Eight year highs and flat…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jan

VIA

Viacom

$42.60

0.45 (1.07%)

, VIAB

Viacom

$38.80

0.79 (2.08%)

13:37
12/09/16
12/09
13:37
12/09/16
13:37
Hot Stocks
Box Office Battle: 'Office Christmas Party' looks to topple 'Moana' »

Opening this weekend, and…

VIA

Viacom

$42.60

0.45 (1.07%)

VIAB

Viacom

$38.80

0.79 (2.08%)

CMCSK

Comcast

CMCSA

Comcast

$69.23

-0.1 (-0.14%)

SNE

Sony

$29.40

0.24 (0.82%)

FOXA

21st Century Fox

$28.64

0.53 (1.89%)

FOX

21st Century Fox

$28.48

0.53 (1.90%)

DIS

Disney

$103.84

0.46 (0.44%)

TWX

Time Warner

$94.89

0.34 (0.36%)

LGF

Lionsgate

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VHC

VirnetX

$2.95

-0.35 (-10.61%)

, AAPL

Apple

$112.12

1.09 (0.98%)

13:32
12/09/16
12/09
13:32
12/09/16
13:32
Hot Stocks
VirnetX says U.S. Federal Circuit Appeals Court issued three appeal decisions »

VirnetX announced that on…

VHC

VirnetX

$2.95

-0.35 (-10.61%)

AAPL

Apple

$112.12

1.09 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

AFL

Aflac

$68.79

-0.83 (-1.19%)

13:25
12/09/16
12/09
13:25
12/09/16
13:25
Options
AFLAC call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:25
12/09/16
12/09
13:25
12/09/16
13:25
General news
Energy Action: Weekly Baker-Hughes rig count »

Energy Action: Weekly…

TTI

TETRA

$4.61

-0.4 (-7.98%)

13:20
12/09/16
12/09
13:20
12/09/16
13:20
Downgrade
TETRA rating change  »

TETRA downgraded on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

$NYE

NYSE Market Internals

13:16
12/09/16
12/09
13:16
12/09/16
13:16
Technical Analysis
NYSE market internals summary »

Breadth is mixed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

13:16
12/09/16
12/09
13:16
12/09/16
13:16
Technical Analysis
NASDAQ market internals summary »

Volume is extremely heavy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$225.83

0.68 (0.30%)

, XLF

Financial Select Sector

$23.64

-0.06 (-0.25%)

13:13
12/09/16
12/09
13:13
12/09/16
13:13
Technical Analysis
On The Fly: ETF fund flow highlights »

The week saw very large…

SPY

SPDR S&P 500 ETF Trust

$225.83

0.68 (0.30%)

XLF

Financial Select Sector

$23.64

-0.06 (-0.25%)

XLP

Consumer Staples Sector SPDR

$51.86

0.56 (1.09%)

XLI

Industrial Select Sector SPDR

$63.87

0.18 (0.28%)

VOO

Vanguard S&P 500 ETF

$207.39

0.65 (0.31%)

JNK

SPDR Barclays High Yield Bond

$36.47

0.0085 (0.02%)

IEMG

iShares Core MSCI Emerging Markets

$43.94

-0.165 (-0.37%)

QQQ

NASDAQ 100 Index Tracking Stock

$118.57

0.21 (0.18%)

USO

United States Oil Fund

$11.42

0.11 (0.97%)

XOP

SPDR Oil Exploration and Production Fund

$43.19

-0.16 (-0.37%)

UWTI

VelocityShares 3x Long Crude Oil ETN

IBB

iShares Nasdaq Biotechnology Index

$268.52

2.24 (0.84%)

GLD

SPDR Gold Trust

$110.63

-0.94 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.